Value of Somatostatin Receptor PET/CT in Patients With MEN1 at Various Stages of Their Disease.
Clément MennetreyMaëlle Le BrasAurélie Bando-DelaunayLaure Al-MansourMagalie HaissaguerreMarie Batisse-LignierEric OuvrardCatherine AnsquerThomas WalterLouis de MestierAntony KellyGhoufrane TliliSophie GiraudMarie-Odile NorthMarie-Françoise OdouBernard GoichotThomas CunyAnderson LoundouPauline RomanetAlessio ImperialeDavid TaïebPublished in: The Journal of clinical endocrinology and metabolism (2022)
This study shows the potential added value of SSTR PET in the assessment of MEN1-associated NETs and provides great impetus toward its implementation in the evaluation of patients with MEN1.